SELLAS Life Sciences Gr (NASDAQ:SLS) just reported results for the first quarter of 2024.
- SELLAS Life Sciences Gr reported earnings per share of -21 cents. This was below the analyst estimate for EPS of -16 cents.
- The company did not report any revenue for the quarter.